Alternatives to Immunai

AI-powered platform for understanding disease biology and accelerating drug discovery.

Develops a computational model of the human body for drug discovery and development.

Variantyx is a precision medicine company offering comprehensive genomic testing solutions for rare genetic disorders, reproductive health, and oncology.

AI-driven drug discovery platform accelerating breakthrough scientific research.

AI-powered spatial biology platform for precision medicine and drug development.

Data-driven drug discovery and development company using machine learning and high-throughput biology.

Ukko is developing novel food allergy and disorder treatments using advanced immunology and plant science.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

Genoox provides a cloud-based AI platform for genomic data analysis, connecting clinicians and healthcare organizations.

Developing genetic medicines and cell therapies for severe diseases using proprietary CRISPR OMNI technology.

AI-powered platform for predicting drug efficacy and safety, reducing clinical trial failures.

Digital therapeutics platform enhancing drug efficacy and safety through personalized software.

Cloud platform for secure sharing and analysis of real-world health data for life sciences.

Israeli-UK biotech company developing novel RNA therapeutics for rare genetic diseases.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

Biotech company using AI and deep RNA analysis to predict cancer treatment response.

Harnessing genetic data for digital insights in rare and germline disorders.

AI platform for accelerating novel peptide therapeutic discovery and development.

Developing a liquid biopsy blood test for early disease detection and monitoring using epigenetic information.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.